Effectiveness of Pregabalin for Treatment of Burning Mouth Syndrome
| Autor: | Osman Nuri Aydin, Ali Akyol, Saliha Yeter Amasyalı, Aslı Akyol Gürses |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Pregabalin Case Report 03 medical and health sciences Behavioral Neuroscience chemistry.chemical_compound 0302 clinical medicine Internal medicine Medicine Duloxetine Pharmacology (medical) In patient business.industry digestive oral and skin physiology Diagnostic test Burning mouth syndrome 030206 dentistry stomatognathic diseases Psychiatry and Mental health chemistry Etiology Anticonvulsants medicine.symptom business 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Clinical Psychopharmacology and Neuroscience |
| ISSN: | 2093-4327 1738-1088 |
| Popis: | Treatment of burning mouth syndrome (BMS) is challenging because there is no consensus regarding pharmalogical or nonpharmalogical therapies. The use of anticonvulsants is controversial. We present nine patients BMS who respond to pregabalin. They were diagnosed secondary BMS except two. Etiologic regulations were made firstly in patients with secondary BMS but symptoms did not decrease. We preferred pregabalin in all patients and got good results. Furthermore the addition of pregabalin to the treatment of two patients who did not respond adequately to duloxetine provided good results. We are only aware that pregabalin may reduce symptoms as a result of case reports. We believe that the diagnosis of pathologic etiology with appropriate diagnostic tests will result in better outcomes in treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|